Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on October 1, 2026

Oct. 1, 2026

Templafy 보고서 “지식근로자 95%, AI 생성 문서를 실제 업무 활용 전에는 수정”

Indeterminate GlobeNewswire

Oct. 1, 2026

Laporan Templafy Mendapati 95% Pekerja Berpengetahuan Menyunting Dokumen yang Dijana AI Sebelum Dokumen Tersebut Sedia Digunakan dalam Perniagaan

Indeterminate GlobeNewswire

Oct. 1, 2026

Relatório da Templafy Revela que 95% dos Profissionais do Conhecimento Editam Documentos Gerados por IA Antes do Uso nos Negócios

Indeterminate GlobeNewswire

Oct. 1, 2026

รายงานจาก Templafy ชี้แรงงานสายความรู้ 95% ต้องแก้ไขเอกสารที่จัดทำโดย AI…

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy 报告发现：95% 的知识工作者在 AI 生成文档达到商用标准前仍需手动编辑

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy 報告發現，95% 的知識工作者在 AI 生成文件準備好用於業務前會先行編輯

Indeterminate GlobeNewswire

Oct. 1, 2026

Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)

Indeterminate GlobeNewswire

Oct. 1, 2026

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Indeterminate GlobeNewswire

Oct. 1, 2026

Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Indeterminate GlobeNewswire

Oct. 1, 2026

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

Indeterminate GlobeNewswire

Oct. 1, 2026

AI Visibility Benchmark for Law Firms and Attorneys Finds No Individual Firm in the Top 20 Across ChatGPT, Gemini, Perplexity and Grok

Indeterminate GlobeNewswire

Oct. 1, 2026

Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies

Indeterminate GlobeNewswire

Oct. 1, 2026

Calian completes sale of U.S. commercial IT business to Trace3

Indeterminate GlobeNewswire

Oct. 1, 2026

Lantronix Secures Blue UAS Companion Computer SOM Listing, Expanding Defense Drone Opportunity

Indeterminate GlobeNewswire

Oct. 1, 2026

Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy Report Finds 95% of Knowledge Workers Edit AI-Generated Documents Before They’re Business-Ready

Indeterminate GlobeNewswire

Oct. 1, 2026

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?

Indeterminate GlobeNewswire

Oct. 1, 2026

Contact Center AI: Why Agent Assist, Quality Monitoring and Coaching Need the Same Feedback Loop

Indeterminate GlobeNewswire

Oct. 1, 2026

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

Indeterminate GlobeNewswire